Regulatory & Access Resources
Use Real-World Evidence to Navigate From Regulatory Approval to Reimbursement Success
This article looks at some of the trends in biosimilars, including three key errors you need to avoid. Particularly, as it pertains to underestimating your risk management plan.
Find out how to plan evidence generation for your value story!
In this article, our gene therapy experts at Health Advances, Parexel’s commercial strategy group, outline considerations for competitively positioning your gene therapy.